Almost every article about what a GLP-1 costs quotes one number, usually the one a particular seller wants quoted. That is not a market rate; it is a sample of one. This desk holds published figures from 456 of 475 sellers on its roster, and the useful thing about a corpus that size is that it can answer the question a single price cannot: how much does the answer vary?
The shape of the semaglutide market
Across 432 sellers publishing a billed monthly figure for compounded semaglutide by injection, the range runs from $69 to $449 — a factor of 6.5. The median is $179, before the charges a headline can leave out. The middle half of the market sits between $135 and $216, which is a band of $81 a month for what is, in most cases, the same molecule prepared by a compounding pharmacy.
The quartiles matter more than the extremes. A reader who finds a seller at $135 is not getting an unusual deal; they are at the twenty-fifth percentile of a large market. A reader paying above $216 is in the top quarter and should be able to say what the extra buys — a named pharmacy, an included consultation, a rate that holds as the dose climbs.
Tirzepatide costs more, consistently
The 394 sellers publishing a figure for compounded tirzepatide by injection run from $75 to $497, with a median of $249. That is $70 a month above the semaglutide median, and the gap holds at the quartiles too rather than being driven by a few expensive outliers, and the format premium sits on top of it for anyone wanting a tablet.
What to do with a distribution
Use it as a position check rather than a target. A quoted figure is worth comparing against the median and the quartiles for the same molecule and format, not against the lowest number on the internet — which on this corpus is $69 and belongs to one seller with its own conditions attached. The six-month totals are the version of this that matters over a course, and whether a rate holds as the dose rises decides whether any of these figures survive month three.
Every number above is computed from this site’s own price records at the moment the page was built, from figures read off sellers’ published pages. The most recent reading in the corpus is September 2026. Nothing here is modeled, forecast or taken from a third party.